Menge{hacek over (s)}, Slovenia

Mihaela Skulj

This inventor holds 1 USPTO granted patent. Top assignee: Lek Pharmaceuticals D.d.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mihaela Skulj. Retrieved from https://idiyas.com/inventor/mihaela-skulj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mihaela Skulj: Innovator in Protein Expression Technology

Introduction

Mihaela Skulj is a prominent inventor based in Mengeš, Slovenia. She has made significant contributions to the field of biotechnology, particularly in the area of protein expression. Her innovative work has led to advancements that can enhance the efficiency of protein production in cell lines.

Latest Patents

Mihaela Skulj holds a patent titled "Reduction of formation of amidated amino acids in cell lines for protein expression." This invention relates to a method designed to reduce peptide amidation activity in specific cell lines. The patent also encompasses cell lines with reduced peptide amidation activity and their various applications in biotechnology.

Career Highlights

Mihaela is currently employed at Lek Pharmaceuticals D.d., a leading pharmaceutical company in Slovenia. Her role at Lek Pharmaceuticals allows her to apply her expertise in biotechnology and contribute to the development of innovative solutions in the pharmaceutical industry.

Collaborations

Mihaela collaborates with Dominik Gaser, who is also involved in the field of biotechnology. Their partnership exemplifies the importance of teamwork in driving innovation and achieving breakthroughs in research.

Conclusion

Mihaela Skulj is a noteworthy inventor whose work in protein expression technology has the potential to impact the biotechnology sector significantly. Her contributions, including her patented methods, highlight her role as a leader in innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…